A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population
A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population
Recruiting · NCT07103148 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, vector-borne disease, viral hemorrhagic fever, viral infectious disease, yellow fever | Recruiting | Phase 3 | 2026-05-06 | NCT07103148 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||